Chemoinformaics analysis of Curcumanolide A & B
| Molecular Weight | 234.339 | nRot | 1 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
| Exact Molecular Weight | 234.162 | nRing | 2 |
| Solubility: LogS | -4.551 | nHRing | 1 |
| Solubility: LogP | 3.78 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.3234 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.393 |
| Synth | 4.809 |
| Natural Product Likeliness | 2.847 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.041 |
| Pgp-sub | 0.061 |
| HIA | 0.007 |
| CACO-2 | -4.572 |
| MDCK | 0.0000217 |
| BBB | 0.559 |
| PPB | 0.791976 |
| VDSS | 1.804 |
| FU | 0.22509 |
| CYP1A2-inh | 0.534 |
| CYP1A2-sub | 0.684 |
| CYP2c19-inh | 0.707 |
| CYP2c19-sub | 0.889 |
| CYP2c9-inh | 0.267 |
| CYP2c9-sub | 0.291 |
| CYP2d6-inh | 0.142 |
| CYP2d6-sub | 0.673 |
| CYP3a4-inh | 0.436 |
| CYP3a4-sub | 0.376 |
| CL | 15.052 |
| T12 | 0.151 |
| hERG | 0.034 |
| Ames | 0.024 |
| ROA | 0.183 |
| SkinSen | 0.406 |
| Carcinogencity | 0.129 |
| EI | 0.087 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.907863 |